Dabigatran and left atrial appendage thrombus

被引:43
作者
Vidal, Alejandro [1 ]
Vanerio, Gabriel [1 ]
机构
[1] CASMU Arrhythmia Serv, Montevideo, Uruguay
关键词
Thrombus; Dabigatran; Atrial fibrillation; MOLECULAR-WEIGHT HEPARIN; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; PLATELET ACTIVATION; FACTOR XA; FIBRILLATION; STROKE; INHIBITORS; PREVENTION; UPDATE; RISK;
D O I
10.1007/s11239-012-0747-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 59-year-old white woman with previous history of arterial hypertension consulted because of palpitations. Atrial fibrillation of uncertain duration was diagnosed. She was not receiving anticoagulants. A trans-esophageal echocardiogram was performed, and a large left atrial appendage thrombus was detected. A strategy of rate control and anti-vitamin K treatment was started. On the subsequent days, we could not reach therapeutic INRs. Therefore, it was decided to stop warfarin and initiate dabigatran. We describe the evolution of the patient, the thrombus resolution, and a successful electrical cardioversion. In our comments, we summarize the natural history of left atrial thrombus, both with and without anticoagulant therapy. We also discuss the differences between warfarin and dabigatran.
引用
收藏
页码:545 / 547
页数:3
相关论文
共 20 条
[1]  
BANNER DW, 1993, ADV EXP MED BIOL, V340, P27
[2]   Stroke prevention in the high-risk atrial fibrillation patient: Medical management [J].
Broukhim M. ;
Halperin J.L. .
Current Cardiology Reports, 2011, 13 (1) :9-17
[3]   THE REGULATION OF HEMOSTASIS - THE PROTEIN-C SYSTEM [J].
CLOUSE, LH ;
COMP, PC .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (20) :1298-1304
[4]   Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Eikelboom, John ;
Oldgren, Jonas ;
Parekh, Amit ;
Pogue, Janice ;
Reilly, Paul A. ;
Themeles, Ellison ;
Varrone, Jeanne ;
Wang, Susan ;
Alings, Marco ;
Xavier, Denis ;
Zhu, Jun ;
Diaz, Rafael ;
Lewis, Basil S. ;
Darius, Harald ;
Diener, Hans-Christoph ;
Joyner, Campbell D. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151
[5]   Drug therapy -: Direct thrombin inhibitors [J].
Di Nisio, M ;
Middeldorp, S ;
Büller, HR .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (10) :1028-1040
[6]   Prevention of Cardioembolic Stroke [J].
Freeman, William David ;
Aguilar, Maria I. .
NEUROTHERAPEUTICS, 2011, 8 (03) :488-502
[7]  
HARENBERG J, 1989, NOUV REV FR HEMATOL, V31, P363
[8]   Synthetic inhibitors of thrombin and factor Xa:: From bench to bedside [J].
Hauptmann, J ;
Stürzebecher, J .
THROMBOSIS RESEARCH, 1999, 93 (05) :203-241
[9]   Stroke Risk and Antithrombotic Strategies in Atrial Fibrillation [J].
Medi, Caroline ;
Hankey, Graeme J. ;
Freedman, Saul B. .
STROKE, 2010, 41 (11) :2705-2713
[10]   The CHADS2 versus the New CHA2DS2-VASc Scoring Systems for Guiding Antithrombotic Treatment of Patients with Atrial Fibrillation: Review of the Literature and Recommendations for Use [J].
Odum, Lauren E. ;
Cochran, Kelly A. ;
Aistrope, Daniel S. ;
Snella, Kathleen A. .
PHARMACOTHERAPY, 2012, 32 (03) :285-296